KYORIN Pharmaceutical Co., Ltd. (TYO:4569)

KYORIN Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	15,012	13,886	19,394	26,994	27,445	31,925
Short-Term Investments	499	99	-	500	3,399	993
Cash & Short-Term Investments	15,511	13,985	19,394	27,494	30,844	32,918
Cash Growth	-19.00%	-27.89%	-29.46%	-10.86%	-6.30%	1.26%
Receivables	45,746	47,672	47,250	41,636	40,409	47,409
Inventory	64,298	53,470	48,025	42,217	38,568	33,282
Other Current Assets	6,417	4,183	4,361	5,029	4,206	3,449
Total Current Assets	131,972	119,310	119,030	116,376	114,027	117,058
Property, Plant & Equipment	30,270	28,950	25,834	24,334	23,896	22,721
Long-Term Investments	23,068	23,882	24,469	27,140	25,074	27,330
Other Intangible Assets	4,854	5,088	5,393	3,289	3,785	3,332
Long-Term Deferred Tax Assets	327	448	1,316	783	343	714
Other Long-Term Assets	1	1	3	2	1	2
Total Assets	190,492	177,679	176,045	171,924	167,126	171,160
Accounts Payable	15,181	14,265	13,762	10,896	6,985	9,776
Accrued Expenses	1,105	2,198	2,182	2,295	2,206	2,334
Short-Term Debt	18,100	10,100	10,300	10,300	10,300	10,400
Current Portion of Long-Term Debt	200	10,200	-	-	-	-
Current Portion of Leases	-	87	134	147	137	141
Current Income Taxes Payable	183	923	2,027	530	476	1,414
Other Current Liabilities	9,873	7,718	6,578	8,014	7,303	7,263
Total Current Liabilities	44,642	45,491	34,983	32,182	27,407	31,328
Long-Term Debt	14,285	435	10,636	10,836	11,036	12,514
Long-Term Leases	-	124	207	341	409	538
Long-Term Deferred Tax Liabilities	175	185	-	175	293	201
Other Long-Term Liabilities	1,093	545	1,038	998	736	729
Total Liabilities	60,420	46,897	50,585	47,417	42,465	48,450
Common Stock	700	700	700	700	700	700
Additional Paid-In Capital	4,752	4,752	4,752	4,752	4,752	4,752
Retained Earnings	136,142	136,774	134,396	132,710	132,557	130,788
Treasury Stock	-17,349	-17,350	-17,666	-17,671	-17,671	-17,706
Comprehensive Income & Other	5,827	5,906	3,278	4,016	4,323	4,176
Shareholders' Equity	130,072	130,782	125,460	124,507	124,661	122,710
Total Liabilities & Equity	190,492	177,679	176,045	171,924	167,126	171,160
Total Debt	32,585	20,946	21,277	21,624	21,882	23,593
Net Cash (Debt)	-17,074	-6,961	-1,883	5,870	8,962	9,325
Net Cash Growth	-	-	-	-34.50%	-3.89%	9.89%
Net Cash Per Share	-297.20	-121.29	-32.86	102.44	156.42	162.78
Filing Date Shares Outstanding	57.45	57.45	57.3	57.3	57.3	57.29
Total Common Shares Outstanding	57.45	57.45	57.3	57.3	57.3	57.29
Working Capital	87,330	73,819	84,047	84,194	86,620	85,730
Book Value Per Share	2264.13	2276.50	2189.38	2172.82	2175.51	2142.06
Tangible Book Value	125,218	125,694	120,067	121,218	120,876	119,378
Tangible Book Value Per Share	2179.64	2187.93	2095.27	2115.43	2109.45	2083.89

Source: S&P Capital IQ. Standard template. Financial Sources.